Tech Company Financing Transactions
NovoStent Funding Round
On 8/17/2005, NovoStent raised $12.8 million in Series B funding from Sanderling Ventures, Band of Angels and Forward Ventures.
Transaction Overview
Company Name
Announced On
8/17/2005
Transaction Type
Venture Equity
Amount
$12,750,000
Round
Series B
Investors
Sanderling Ventures (Lead Investor) (Timothy Mills)
Montreux Equity Partners (Howard Palefsky)
Proceeds Purpose
This additional capital will allow us to develop more robust human data as we determine the Company's strategic direction.
Company Information
Company Status
Out of Business
Industry
Medical Devices & Instruments
Mailing Address
1400 Terra Bella Ave E
Mountain View, CA 94043
USA
Mountain View, CA 94043
USA
Phone
Website
Email Address
Overview
NovoStent Corporation is a medical device company that has developed a novel anchored helical stent technology to provide a wide range of vascular therapies.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Rick Randall
Browse more venture capital transactions:
Prev: 8/16/2005: Transera Communications venture capital transaction
Next: 8/17/2005: Peppercoin venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. All VC database entries reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs